К основному контенту

Adalat

Adalat

     * Generic Name: nifedipine
     * Brand Name: Adalat CC


     * What is nifedipine?
     * What are the possible side effects of nifedipine?
     * What is the most important information I should know about
       nifedipine?
     * What should I discuss with my healthcare provider before taking
       nifedipine?
     * How should I take nifedipine?
     * What happens if I miss a dose?
     * What happens if I overdose?
     * What should I avoid while taking nifedipine?
     * What other drugs will affect nifedipine?
     * Where can I get more information?

What is nifedipine?

   Nifedipine is in a group of drugs called calcium channel
   blockers. It works by relaxing the muscles of your heart and blood
   vessels.

   Nifedipine is used to treat hypertension (high blood pressure)
   and angina (chest pain).

   Nifedipine may also be used for purposes not listed in this medication
   guide.

What are the possible side effects of nifedipine?

   Get emergency medical help if you have signs of an allergic reaction:
   hives; difficult breathing; swelling of your face, lips, tongue, or
   throat.

   Call your doctor at once if you have:
     * worsening angina;
     * a light-headed feeling, like you might pass out;
     * pounding heartbeats or fluttering in your chest;
     * chest pain or heavy feeling, pain spreading to the jaw or
       shoulder, nausea, sweating, general ill feeling;
     * swelling in your ankles or feet; or
     * upper stomach pain, jaundice (yellowing of the skin or eyes).

   Common side effects may include:
     * mild dizziness;
     * flushing (warmth, redness, or tingly feeling);
     * weakness, headache, mood changes;
     * heartburn, nausea;
     * tremors, muscle cramps; or
     * cough, wheezing, sore throat, stuffy nose.

   This is not a complete list of side effects and others may occur. Call
   your doctor for medical advice about side effects. You may report side
   effects to FDA at 1-800-FDA-1088.

What is the most important information I should know about nifedipine?

   You should not use nifedipine if you have severe coronary artery
   disease, or if you have had a heart attack within the past 2 weeks.

   Adalat Patient Information including How Should I Take
   High Blood Pressure: Learn About Hypertension

   High Blood Pressure Slideshow Pictures
   RxList

   Take the Salt Quiz!
   Lowering Blood Pressure:Exercise Tips for Getting Started

   Lowering Blood Pressure Exercise Tips Pictures

What should I discuss with my healthcare provider before taking nifedipine?

   You should not use this medicine if you are allergic to nifedipine, if
   you have severe coronary artery disease, or if you have had a heart
   attack within the past 2 weeks.

   To make sure nifedipine is safe for you, tell your doctor if you have:
     * severe COPD (chronic obstructive pulmonary disease);
     * kidney disease;
     * congestive heart failure; or
     * if you take other medications, especially an antibiotic or
       antifungal medicine, an antidepressant, heart or blood
       pressure medicine, or drugs to treat HIV/AIDS or
       hepatitis C.

   It is not known whether nifedipine will harm an unborn baby. Tell your
   doctor if you are pregnant or plan to become pregnant.

   Nifedipine can pass into breast milk and may harm a nursing baby. Tell
   your doctor if you are breast-feeding a baby.

   The nifedipine extended-release tablet may contain lactose. Talk to
   your doctor before using this form of nifedipine if you have
   galactose intolerance, or severe problems with lactose (milk
   sugar).

How should I take nifedipine?

   Follow all directions on your prescription label. Your doctor may
   occasionally change your dose to make sure you get the best results. Do
   not take this medicine in larger or smaller amounts or for longer than
   recommended.

   You may need to take an extended-release tablet on an empty stomach.
   Follow the directions on your medicine label about taking this
   medication with or without food.

   Do not crush, chew, or break an extended-release tablet. Swallow it
   whole.

   Your blood pressure will need to be checked often and you may need
   other blood tests at your doctor's office.

   Some tablet forms of nifedipine are made with a shell that is not
   absorbed or melted in the body. Part of the tablet shell may appear in
   your stool. This is a normal side effect of nifedipine and will not
   make the medication less effective.

   If you need surgery, tell the surgeon ahead of time that you are
   using nifedipine. You may need to stop using the medicine at least 36
   hours before surgery.

   You may have very low blood pressure while taking this medication.
   Call your doctor if you are sick with vomiting or diarrhea, or if
   you are sweating more than usual.

   If you are also taking a beta-blocker (atenolol, carvedilol,
   labetalol, metoprolol, nadolol, nebivolol, propranolol,
   sotalol, and others) you should not stop using the beta-blocker
   suddenly or you could have serious heart problems that will not be
   prevented by nifedipine. Follow your doctor's instructions about
   tapering your beta-blocker dose.

   You should not stop using nifedipine suddenly. Stopping suddenly may
   make your condition worse.

   If you are being treated for high blood pressure, keep using this
   medication even if you feel well. High blood pressure often has no
   symptoms. You may need to use blood pressure medication for the rest of
   your life.

   Store at room temperature away from moisture, heat, and light.

   Adalat Patient Information including If I Miss a Dose
   High Blood Pressure: Learn About Hypertension

   High Blood Pressure Slideshow Pictures
   RxList

   Take the Salt Quiz!
   Lowering Blood Pressure:Exercise Tips for Getting Started

   Lowering Blood Pressure Exercise Tips Pictures

What happens if I miss a dose?

   Take the missed dose as soon as you remember. Skip the missed dose if
   it is almost time for your next scheduled dose. Do not take extra
   medicine to make up the missed dose.

What happens if I overdose?

   Seek emergency medical attention or call the Poison Help line at
   1-800-222-1222.

What should I avoid while taking nifedipine?

   Grapefruit and grapefruit juice may interact with nifedipine and
   lead to unwanted side effects. Discuss the use of grapefruit products
   with your doctor.

   Avoid getting up too fast from a sitting or lying position, or you may
   feel dizzy. Get up slowly and steady yourself to prevent a fall.

What other drugs will affect nifedipine?

   Other drugs may interact with nifedipine, including prescription and
   over-the-counter medicines, vitamins, and herbal products. Tell each of
   your health care providers about all medicines you use now and any
   medicine you start or stop using.

Where can I get more information?

   Your pharmacist can provide more information about nifedipine.
     __________________________________________________________________


Комментарии

Отправить комментарий

Популярные сообщения из этого блога

A healthy diet may trigger a better response to a certain kind of melanoma treatment. How?

New research suggests that a diet that's full of fiber appears to lead to more diverse intestinal bacteria (microbiome). In turn, a thriving gut microbiome is linked to a stronger response to an immune therapy for the aggressive skin cancer. "We found that patients eating a high-fiber diet at the start of therapy were about five times more likely to respond to the anti-PD-1 immunotherapy," said study author Christine Spencer. She's a research scientist with the Parker Institute for Cancer Immunotherapy in San Francisco. Anti-PD-1 immunotherapy helps the immune system recognize cancer cells as dangerous cells that need to be destroyed, according to the American Cancer Society (ACS). The cancer drugs Keytruda and Opdivo are examples of this type of immunotherapy. Melanoma is a type of skin cancer. It only accounts for about 1 percent of all skin cancers, but is responsible for most skin cancer deaths, the ACS says. Several recent studies have suggested that a ...
4 комментария
Далее...

American Heart Association News

On Feb. 1, 1961, twins Debbie and Donna Horst arrived at the White House to fanfare. The 6-year-olds, decked out in fancy dresses and satin sashes, found themselves surrounded by a pressing crowd and a sea of blinding flashbulbs as they made their way to see Jacqueline Kennedy. The girls -- both born with holes in their aortas -- were meeting with the first lady to kick off a national campaign to raise awareness about congenital heart defects. "There were hundreds of reporters because this was Jacqueline Kennedy' first public act as first lady," Debbie said. She recalls being startled when the reporters asked Mrs. Kennedy if they could move in closer. "It was frightening because they all jumped at us at once." The Pennsylvania twins, just a few weeks from turning 7, were among the first "Heart Fund Sweethearts" in the campaign to raise money as well as awareness. The month before, they'd met up with Micki and Patricia Gane, also of Pennsylvania...
4 комментария
Далее...

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla PRINCETON, N.J., May 17, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it has resubmitted to the U.S. Food and Drug Administration (FDA) the NDA for its lead product candidate, Twirla®, an investigational low-dose combined hormonal contraceptive patch (AG200-15).  Agile resubmitted the NDA in response to a December 2017 Complete Response Letter (CRL) from the FDA, which identified deficiencies relating to (i) quality control adhesion test methods for the Twirla manufacturing process, (ii) observations identified during an inspection of a facility of our third-party manufacturer for the Twirla NDA that must be resolved, and (iii) questions on the in vivo adhesion properties of Twirla and their potential relationship to the SECURE clinical trial results. The resubmitted NDA includes the results from a...
Отправить комментарий
Далее...